• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

With 2 planned launches, Boehringer Ingelheim looks to make a name for itself in oncology

cafead

Administrator
Staff member
  • cafead   Jun 10, 2024 at 06:12: PM
via With 25 launches planned through 2030, Boehringer Ingelheim is gearing up for a busy few years. As a part of that, the German drugmaker is looking forward to flexing its oncology muscles with two new cancer drug launches in 2025.

article source
 

<